Skip to Content


In the US, Dapagliflozin (dapagliflozin systemic) is a member of the drug class SGLT-2 inhibitors and is used to treat Diabetes, Type 2.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Oral antidiabetic agent: sodium-glucose co-transporter 2 (SGLT2) inhibitor

Chemical Name

(1S)-1,5-anhydro-1-C-{4-chloro-3-[(4-etoxyphenyl)metyl]phenyl}-D-glucitol (WHO)

Foreign Names

  • Dapagliflozinum (Latin)
  • Dapagliflozin (German)
  • Dapagliflozine (French)
  • Dapagliflozina (Spanish)

Generic Names

  • Dapagliflozin (OS: USAN)
  • BMS-512148 (IS)
  • BMS 512148-05 (IS)
  • Dapagliflozin propanediol monohydrate (IS)
  • Dapagliflozin, mixture with propylene glycol, hydrate (IS)
  • UNII-887K2391VH (IS)

Brand Names

  • Farxiga
    Bristol-Myers Squibb, United States
  • Forxiga
    AstraZeneca, Australia; AstraZeneca, Chile; AstraZeneca, Hong Kong; AstraZeneca, Croatia (Hrvatska); AstraZeneca, Malaysia; AstraZeneca, Slovenia; AstraZeneca, Thailand; AstraZeneca AB, Cyprus; Bristol Myers Squibb, Spain; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Slovakia
  • Xigduo (Dapagliflozin and Metformin)
    AstraZeneca, Croatia (Hrvatska); Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Poland
  • Forxiga
    AstraZeneca, Canada; AstraZeneca, Switzerland; AstraZeneca, Germany; AstraZeneca, Finland; AstraZeneca, Ireland; AstraZeneca, Iceland; AstraZeneca, Norway; AstraZeneca, New Zealand; AstraZeneca, Sweden; AstraZeneca Singapore, Singapore; AstraZeneca UK, United Kingdom; Bristol Myers Squibb, Israel; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb/AstraZeneca, Austria
  • Xigduo (Dapagliflozin and Metformin)
    AstraZeneca, Finland; AstraZeneca, Norway; AstraZeneca, Sweden; AstraZeneca UK, United Kingdom; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb/AstraZeneca, Austria; Bristol-Myers Squibb/AstraZeneca, Germany
  • Xigduo XR (Dapagliflozin and Metformin)
    AstraZeneca, Switzerland


ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.